Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Wynn

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
General Dentistry|February 25, 2000
New drug approvals in 1998R L Wynn
General Dentistry|February 25, 2000
Atrial fibrillation: medications and dental considerationsR L Wynn
General Dentistry|February 24, 2001
New drug approvals in 1999R L Wynn
General Dentistry|February 24, 2001
The top 50 prescription medications dispensed in pharmacies in 1999R L Wynn
General Dentistry|February 24, 2001
The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex)R L Wynn
General Dentistry|February 24, 2001
Osteoporosis, alveolar bone loss, and drug developmentR L Wynn
Journal of the California Dental Association|April 28, 2001
Cardiovascular drugs and dental considerationsR L Wynn
General Dentistry|January 1, 1994
Epinephrine interactions with beta-blockersR L Wynn
Journal of the Baltimore College of Dental Surgery|July 1, 1971
Interactions of drugs used in dentistry-clinical implications and methods of preventionR L Wynn
General Dentistry|January 1, 1995
FDA drug approvals in 1993-94R L Wynn
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
General Dentistry|February 25, 2000
New drug approvals in 1998R L Wynn
General Dentistry|February 25, 2000
Atrial fibrillation: medications and dental considerationsR L Wynn
General Dentistry|February 24, 2001
New drug approvals in 1999R L Wynn
General Dentistry|February 24, 2001
The top 50 prescription medications dispensed in pharmacies in 1999R L Wynn
General Dentistry|February 24, 2001
The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex)R L Wynn
General Dentistry|February 24, 2001
Osteoporosis, alveolar bone loss, and drug developmentR L Wynn
Journal of the California Dental Association|April 28, 2001
Cardiovascular drugs and dental considerationsR L Wynn
General Dentistry|January 1, 1994
Epinephrine interactions with beta-blockersR L Wynn
Journal of the Baltimore College of Dental Surgery|July 1, 1971
Interactions of drugs used in dentistry-clinical implications and methods of preventionR L Wynn
General Dentistry|January 1, 1995
FDA drug approvals in 1993-94R L Wynn
Pageof 9